While there has been a plethora of good news regarding the COVID-19 pandemic—from declining case rates to increasing numbers of Americans being vaccinated—Anthony Fauci, MD, director of the National Institute of Allergy and Infectious…

For the third week in a row, the number of children diagnosed with COVID-19 has declined. During the week of January 29 to February 4, 118,000 new cases were found among children, down from 200,000 during the week of January 8 to 14. Thus…

Millions of counterfeit N95 respirators have entered the United States market, bypassing American investigators charged with noting such fakes. Healthcare workers from Washington State to New Jersey have notified authorities about receiving…

Those who have received two doses of either the Pfizer or Moderna COVID-19 vaccine no longer need to quarantine if they come in contact with someone infected with SARS-CoV-2, according to the United States Centers for Disease Control and…

The COVID-19 vaccination is designed to elicit an immune response to the SARS-CoV-2 spike protein, teaching the body how to fight off infection. This immune response often materializes as fever, chills, headache, and fatigue. This is good…

Results from a poll taken the week of January 18 show that 88% of patients have either already sought dental care or are planning to do so. The poll, conducted by the American Dental Association Health Policy Institute (ADA HPI), also found…

During the week of February 1, the United States experienced a 25% decrease in new COVID-19 cases and a 15% reduction in the number of patients hospitalized due to COVID-19 illness. These significant drops follow 4 weeks of declines in new…

As it is estimated that at least 75% of Americans need to be vaccinated against SARS-CoV-2 in order to achieve herd immunity, the race is on to see which states can vaccinate their residents the quickest. Globally, Israel—with a population…

Developed in the United Kingdom, the COVID-19 vaccine from AstraZeneca and the University of Oxford has shown 74.6% effectiveness against the new, more contagious UK-based variant, B117, of SARS-CoV-2. The research results were published…

Johnson & Johnson (J&J) has applied for an Emergency Use Authorization (EUA)  from the United States Food and Drug Administration (FDA) for its one-shot COVID-19 vaccine, which has shown 66% efficacy in preventing moderate to severe…